Find uplifting stories about heroes, innovations, and solutions
5 results for "tzield"
Australia has approved Tzield, the first therapy in over 100 years that can delay the onset of type 1 diabetes by an average of two years. The breakthrough gives families precious time before the daily burden of insulin therapy begins.
Australia just approved the first new type 1 diabetes therapy since insulin was discovered over a century ago. The treatment can delay disease progression by an average of two years, giving families precious time before daily insulin begins.
Two children at BC Children's Hospital became the first in Canada to receive a treatment that can delay type 1 diabetes by about two years. This marks a historic shift from just managing the disease to actually changing its course.
Australia just approved the first treatment in 100 years that can delay type 1 diabetes before symptoms even appear. Teplizumab gives families precious extra time without insulin therapy, fear, and constant medical monitoring.
A groundbreaking treatment can now delay type 1 diabetes for up to three years, giving families precious time before symptoms begin. The NHS has approved the first-ever drug that stops the disease in its tracks during early stages.